Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

PBM Fees Under Medicare Would Be Reported To DoJ, HHS In Senate Bill

Executive Summary

PBMs administering Medicare drug plans would be required to report all payments received from drug manufacturers to the Department of Justice and the HHS Inspector General under the Senate's Medicare legislation
Advertisement

Related Content

PBM Disclosure Requirements On Rx Switches Likely To Increase Costs – FTC
PBM Disclosure Requirements On Rx Switches Likely To Increase Costs – FTC
PBM/Manufacturer Therapeutic Substitution Contracts Sought In FTC Study
PBM/Manufacturer Therapeutic Substitution Contracts Sought In FTC Study
NCPA To Target Payors In “Life Or Death” Campaign Against PBMs
PBMs Sue Over Maine Law; Seek Constitutional Protection For Rebates
PBM, Chain Drug Summer Lobbying Focuses On Mail-Order Rx In Medicare
Medicare PBM Restrictions Would Lead To Higher Premiums, CBO Says
Reproductive Toxicity Factors Weighted Equally To Guard Against Bias - FDA
Reproductive Toxicity Factors Weighted Equally To Guard Against Bias - FDA
Advertisement
UsernamePublicRestriction

Register

PS042058

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel